Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands

Brechje de Gier, Stijn Andeweg, Jantien A. Backer, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Susan van den Hof, Hester E. de Melker, Mirjam J. Knol
doi: https://doi.org/10.1101/2021.10.14.21264959

Article usage

Article usage: October 2021 to October 2024

AbstractFullPdf
Oct 20211944725332856
Nov 20215193052946209
Dec 20213345631562108
Jan 20221311318281076
Feb 20224147396264
Mar 20221492211178
Apr 202211127194
May 202289711780
Jun 20228009351
Jul 2022114811158
Aug 20227067378
Sep 20224746449
Oct 202289623991
Nov 20226978355
Dec 20223532727
Jan 20233164830
Feb 20232714627
Mar 20232001720
Apr 20234384816
May 20231711914
Jun 20231411413
Jul 20231811922
Aug 20231602921
Sep 20231043322
Oct 20231251547
Nov 20231043814
Dec 2023962233
Jan 2024821016
Feb 2024871922
Mar 20241061427
Apr 20241282521
May 2024961221
Jun 2024961830
Jul 20241111027
Aug 20241102729
Sep 2024991248
Oct 20241492618
Back to top
Posted October 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands
Brechje de Gier, Stijn Andeweg, Jantien A. Backer, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Susan van den Hof, Hester E. de Melker, Mirjam J. Knol
medRxiv 2021.10.14.21264959; doi: https://doi.org/10.1101/2021.10.14.21264959
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area